14 April 2021, 7:43 pm EDT By
On Wednesday, April 14, officials halted the use of the Johnson & Johnson COVID-19 vaccine in the United States to gather more information about the clots that were reported in six people who received the shot.
The Centers for Disease Control and Prevention s independent advisory committee stated that the CDC did not have enough information to say which populations would be at risk of blood clots or to recommend who should obtain this vaccine. There are also concerns that this rare clotting can contribute to other problems with the vaccine.
Johnson & Johnson COVID-19 Vaccine Can Cause Clotting
(Photo : Photo by Macau Photo Agency on Unsplash)
Pause on J&J Vaccination in U S Continues as CDC Committee Asks for More Data
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
J&J vaccine remains on pause as CDC panel requests more information
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
Johnson & Johnson COVID-19 vaccine pause continues as officials ask for more data
An independent committee didn’t have enough information to make a decision
Share this story
Photo By Tom Williams/CQ-Roll Call, Inc via Getty Images
Use of the Johnson & Johnson COVID-19 vaccine remains paused in the United States as officials gather more information about the rare clots reported in six people who got the shot. An independent advisory committee to the Centers for Disease Control and Prevention said it didn’t have enough information yet to say which groups might be at risk of the clots or to recommend who should get this vaccine.
Vaccinating by age groups is unfair, particularly to minorities, advisory panel tells CDC
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.